Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) (IMA)
Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency) is the official source of medicine shortage information for Iceland (Europe). Mederti checks its register daily and links every notice back to the original publication.
- Official register
- lyfjastofnun.is
- Country
- Iceland
- Notices tracked by Mederti
- 3,387
- Last checked
- 8 Nov 2026
Latest notices from IMA
- Propofolum — active, medium, since 6 Nov 2026 (source)
- Latanoprostum — active, medium, since 6 Nov 2026 (source)
- Blanda — active, low, since 5 Nov 2026 (source)
- Selumetinibum — active, medium, since 5 Nov 2026 (source)
- Aripiprazolum — active, medium, since 5 Nov 2026 (source)
- Propofolum — active, medium, since 5 Nov 2026 (source)
- Azithromycinum — active, medium, since 5 Nov 2026 (source)
- Ofatumumabum — active, low, since 4 Nov 2026 (source)
- Glucagonum — active, medium, since 4 Nov 2026 (source)
- Human Normal Immunoglobulin — active, medium, since 4 Nov 2026 (source)
- Tipiracilum — active, high, since 3 Nov 2026 (source)
- Natalizumabum — active, low, since 3 Nov 2026 (source)
- Human Follitropin Alfa, Recombinant — active, medium, since 2 Nov 2026 (source)
- Rivaroxabanum — active, medium, since 2 Nov 2026 (source)
- Rabeprazolum — active, medium, since 2 Nov 2026 (source)
Every IMA notice, searchable and alertable
Search Iceland's full register alongside 50+ other countries — free for individual pharmacists and clinicians.
Create a free accountMederti is not affiliated with or endorsed by Lyfjastofnun — Tilkynntur lyfjaskortur (Iceland Medicines Agency). All notices remain the property of their publisher and are linked to the original source.